Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRbg Holdings Regulatory News (RBGP)

  • This share is currently suspended. It was suspended at a price of 0.89
  • There is currently no data for RBGP

Investor Presentation

21 Jan 2022 07:00

RNS Number : 1555Z
RBG Holdings PLC
21 January 2022
 

Reach

 

21 January 2022

 

RBG Holdings plc

("the Group" or "the Company")

 

Investor Presentation

 

RBG Holdings plc (AIM: RBGP), the professional services group, is expected to publish a pre-close trading update for the twelve months ending 31 December 2021 on 27 January 2022. The Company will provide a live investor presentation via the Investor Meet Company (IMC) platform on 27 January 2022 at 10.00am.

 

Hosted by CEO, Nicola Foulston, the online presentation is open to all existing and potential shareholders. Investors can sign up to Investor Meet Company for free and add RBG Holdings plc via

https://www.investormeetcompany.com/rbg-holdings-plc/register-investor

Investors who have already registered and added to meet the Company, will be automatically invited.

Questions can be submitted pre-event via the IMC dashboard or any time during the live presentation via the "Ask a Question" function.

 

Although the Company may not be able to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market.

 

Responses to the Q&A from the live presentation will be published at the earliest opportunity on the IMC platform. Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base.

 

Enquiries:

 

SECNewgate

Tel: +44 (0)7540 106366

Robin Tozer/ /Isabelle Smurfit

rbg@secnewgate.co.uk

 

About RBG Holdings plc

RBG Holdings plc is a professional services group, which comprises the following divisions:

 

RBG Legal Services Limited ("RBGLS")

RBGLS is the Company's legal services division which combines the businesses previously operated by Rosenblatt Limited and Memery Crystal Limited.

 

 

Rosenblatt

Rosenblatt is one of the UK's pioneering legal practices and a leader in dispute resolution. Rosenblatt provides a range of legal services to its diversified client base, which includes companies, banks, entrepreneurs and individuals. Complementing this is Rosenblatt's increasingly international footprint, advising on complex cross-jurisdictional disputes.

 

 

Memery Crystal

Memery Crystal offers legal services in a range of areas such as corporate (including a market-leading corporate finance offering), real estate, commercial, IP & technology (CIPT), banking & finance, tax & wealth structuring and employment. Memery Crystal is one of the leading legal practices in the UK to advise the emerging cannabis sector on a wide range of business issues. Memery Crystal offers a partner-led service to a broad range of clients, from multinational companies, financial institutions and owner-managed businesses to individual entrepreneurs.

 

LionFish Litigation Finance Limited ("LionFish")

The Company also provides litigation finance in selected cases through a separate arm, LionFish Litigation Finance Limited. LionFish finances litigation matters being run by other solicitors in return for a significant return on the outcome of those cases. As such, the Company has two types of litigation assets - Rosenblatt's own client matters, and litigation matters run by third-party solicitors. LionFish is positioned to be a unique, alternative provider to the traditional litigation funders.

 

Convex Capital Limited ("Convex Capital")

Convex Capital is a specialist sell-side corporate finance boutique based in Manchester. Convex Capital is entirely focused on helping companies, particularly owner-managed and entrepreneurial businesses, realise their value through sales to large corporates. Convex Capital identifies and proactively targets firms that it believes represent attractive acquisition opportunities.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFZGZMNGMGZZM
Date   Source Headline
4th May 20217:00 amRNSPurchase of Shares by Directors of Convex
20th Apr 20218:00 amRNSLionFish - first successful litigation investment
20th Apr 20217:01 amRNSResults for the year ended 31 December 2020
20th Apr 20217:00 amRNSAcquisition of Memery Crystal
16th Apr 20212:32 pmRNSElectronic Communications
15th Apr 20217:00 amRNSPurchase of Shares by Directors of Convex
6th Apr 20217:00 amRNSPurchase of Shares by Directors of Convex
1st Apr 20217:00 amRNSInvestor Presentation
26th Mar 20217:00 amRNSPurchase of Shares by Directors of Convex
5th Mar 20217:00 amRNSConvex Capital Update
2nd Mar 20219:48 amRNSPurchase of Shares by Directors of Convex
24th Feb 20217:00 amRNSCapital Markets Day
17th Feb 20217:00 amRNSLitigation Finance Presentation
15th Feb 20217:00 amRNSUpcoming Investor Presentations
8th Feb 20217:00 amRNSNew Managing Director at RBL & Convex Update
3rd Feb 20217:00 amRNSPurchase of Shares by Directors of Convex
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:01 pmRNSPrice Monitoring Extension
28th Jan 202111:06 amRNSSecond Price Monitoring Extn
28th Jan 202111:00 amRNSPrice Monitoring Extension
28th Jan 20219:05 amRNSSecond Price Monitoring Extn
28th Jan 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSTrading Update & Investor Presentation
5th Jan 202112:05 pmRNSHolding(s) in Company
11th Nov 202010:00 amRNSPurchase of shares / PDMR Shareholding
6th Oct 20207:00 amRNSTrading & Market Guidance Update
16th Sep 20202:06 pmRNSSecond Price Monitoring Extn
16th Sep 20202:00 pmRNSPrice Monitoring Extension
16th Sep 20207:00 amRNSUnaudited Interim Results
2nd Sep 20201:18 pmRNSRetail Investor Presentation
14th Jul 20207:00 amRNSLaunch of financing solution for insolvency claims
13th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSPre-close Trading Update
18th Jun 20201:53 pmRNSResult of AGM
1st Jun 20207:00 amRNSAppointment of Broker
20th May 20207:00 amRNSDividend Update and AGM Arrangements
21st Apr 20207:00 amRNSFull Year Results
16th Apr 20207:00 amRNSLitigation Investment Update
6th Apr 20207:00 amRNSTrading and COVID-19 Update
6th Feb 20203:58 pmRNSAppointment of Joint Broker
5th Feb 20202:35 pmRNSChange of Website
24th Jan 20207:00 amRNSTrading Update & Directorate Change
6th Jan 20207:01 amRNSLord Hogan-Howe appointed as an adviser
6th Jan 20207:00 amRNSSettlement of Project Blue Sky
29th Nov 20197:21 amRNSDirector/PDMR Shareholding
20th Nov 201911:25 amRNSDirector/PDMR Shareholding
26th Sep 20195:25 pmRNSDividend Declaration
25th Sep 20197:00 amRNSUnaudited Interim Results
16th Sep 20197:00 amRNSAcquisition of Convex Capital Limited
9th Sep 20197:00 amRNSNew White Collar Fraud & Financial Crime Division

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.